Search
Once-a-week insulin treatment could be game-changing for patients with diabetes : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/once-a-week-insulin-treatment.html
Treating people with Type 2 diabetes with a new once-a-week injectable insulin therapy proved to be safe and as effective as daily insulin injections
Study reveals how RNA-modifying enzyme picks its targets: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2026/june-rna-modifying-enzyme.html
An RNA-modifying enzyme linked to cancer and neurological disorders selects its targets by recognizing specific RNA shapes and sequences, according to a study by UT Southwestern Medical Center researchers.
Scientists identify new gene involved in autism spectrum disorder: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/new-gene-autism-spectrum-disorder.html
UT Southwestern scientists have adapted a classic research technique called forward genetics to identify new genes involved in autism spectrum disorder (ASD).
Exercise boosts blood flow to the brain, study finds: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/exercise-boosts-blood-flow-to-the-brain.html
It’s not just your legs and heart that get a workout when you walk briskly; exercise affects your brain as well.
Speeding treatment for urinary tract infections in children: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/speeding-treatment-for-urinary-tract-infections-in-children.html
A study led by UT Southwestern and Children’s Health researchers defines parameters for the number of white blood cells that must be present in children’s urine at different concentrations to suggest a urinary tract infection (UTI).
Hope for children with bow hunter syndrome: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/hope-for-children-with-bow-hunter-syndrome.html
Fusing the neck’s top two vertebrae can prevent repeat strokes in children with bow hunter syndrome, a rare condition that affects a handful of U.S. pediatric patients each year, UT Southwestern researchers suggest in a recent study.
Bringing bad proteins back into the fold: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/bringing-bad-proteins-back-into-the-fold.html
A new nanoparticle-based drug can boost the body’s innate immune system and make it more effective at fighting off tumors, researchers at UT Southwestern have shown.
Study finds low risk of pregnancy complications from COVID-19: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2020/low-risk-pregnancy-complications-covid.html
Pregnant women who test positive for COVID-19 and their newborn babies have a low risk of developing severe symptoms, according to a new study from UT Southwestern.
Protein that can be toxic in the heart and nerves may help prevent Alzheimer’s: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/protein-that-can-be-toxic-in-the-heart-and-nerves.html
A protein that wreaks havoc in the nerves and heart when it clumps together can prevent the formation of toxic protein clumps associated with Alzheimer’s disease
Children’s Medical Center Dallas seeks community participation in trauma research study to investigate treatment strategies for critically injured children : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/sept-cmcd-trauma-research-study.html
Bleeding is the most common cause of preventable death after injury. Researchers at Children’s Medical Center Dallas are seeking community consultation for possible future participation from parents and legal guardians in a study that will compare two resuscitation treatments (whole blood versus traditional blood component therapy, and tranexamic acid versus no tranexamic acid) for children ages 1 month to 18 years old.